Literature DB >> 21130158

Magnetic resonance imaging of organic contrast agents in mice: capturing the whole-body redox landscape.

Ryan M Davis1, Shingo Matsumoto, Marcelino Bernardo, Anastasia Sowers, Ken-Ichiro Matsumoto, Murali C Krishna, James B Mitchell.   

Abstract

Nitroxides are a class of stable free radicals that have several biomedical applications including radioprotection and noninvasive assessment of tissue redox status. For both of these applications, it is necessary to understand the in vivo biodistribution and reduction of nitroxides. In this study, magnetic resonance imaging was used to compare tissue accumulation (concentration) and reduction of two commonly studied nitroxides: the piperidine nitroxide Tempol and the pyrrolidine nitroxide 3-CP. It was found that 3-CP was reduced 3 to 11 times slower (depending on the tissue) than Tempol in vivo and that maximum tissue concentration varies substantially between tissues (0.6-7.2mM). For a given tissue, the maximum concentration usually did not vary between the two nitroxides. Furthermore, using electron paramagnetic resonance spectroscopy, we showed that the nitroxide reduction rate depends only weakly on cellular pO(2) in the oxygen range expected in vivo. These observations, taken with the marked variation in nitroxide reduction rates observed between tissues, suggest that tissue pO(2) is not a major determinant of the nitroxide reduction rate in vivo. For the purpose of redox imaging, 3-CP was shown to be an optimal choice based on the achievable concentrations and bioreduction observed in vivo. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21130158      PMCID: PMC3031128          DOI: 10.1016/j.freeradbiomed.2010.11.028

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  45 in total

1.  High-resolution mapping of tumor redox status by magnetic resonance imaging using nitroxides as redox-sensitive contrast agents.

Authors:  Ken-Ichiro Matsumoto; Fuminori Hyodo; Atsuko Matsumoto; Alan P Koretsky; Anastasia L Sowers; James B Mitchell; Murali C Krishna
Journal:  Clin Cancer Res       Date:  2006-04-15       Impact factor: 12.531

Review 2.  Role of superoxide dismutase in cancer: a review.

Authors:  L W Oberley; G R Buettner
Journal:  Cancer Res       Date:  1979-04       Impact factor: 12.701

3.  Superoxide dismutase: correlation with life-span and specific metabolic rate in primate species.

Authors:  J M Tolmasoff; T Ono; R G Cutler
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

4.  A novel metal-free low molecular weight superoxide dismutase mimic.

Authors:  A Samuni; C M Krishna; P Riesz; E Finkelstein; A Russo
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

5.  Cellular sites of H2O2-induced damage and their protection by nitroxides.

Authors:  A M Samuni; W DeGraff; M C Krishna; J B Mitchell
Journal:  Biochim Biophys Acta       Date:  2001-02-16

6.  Production of large amounts of hydrogen peroxide by human tumor cells.

Authors:  T P Szatrowski; C F Nathan
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

7.  Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol.

Authors:  J B Mitchell; W DeGraff; D Kaufman; M C Krishna; A Samuni; E Finkelstein; M S Ahn; S M Hahn; J Gamson; A Russo
Journal:  Arch Biochem Biophys       Date:  1991-08-15       Impact factor: 4.013

8.  Evaluation of tempol radioprotection in a murine tumor model.

Authors:  S M Hahn; F J Sullivan; A M DeLuca; C M Krishna; N Wersto; D Venzon; A Russo; J B Mitchell
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

9.  Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients.

Authors:  Dirk Rades; Fabian Fehlauer; Amira Bajrovic; Birgit Mahlmann; Eckart Richter; Winfried Alberti
Journal:  Radiother Oncol       Date:  2004-03       Impact factor: 6.280

Review 10.  Radioprotection.

Authors:  Joel S Greenberger
Journal:  In Vivo       Date:  2009 Mar-Apr       Impact factor: 2.155

View more
  23 in total

1.  Imaging of superoxide generation in the dopaminergic area of the brain in Parkinson's disease, using mito-TEMPO.

Authors:  Zhivko Zhelev; Rumiana Bakalova; Ichio Aoki; Dessislava Lazarova; Tsuneo Saga
Journal:  ACS Chem Neurosci       Date:  2013-09-16       Impact factor: 4.418

2.  Reduction kinetics and electrochemistry of tetracarboxylate nitroxides.

Authors:  Shengdian Huang; Hui Zhang; Joseph T Paletta; Suchada Rajca; Andrzej Rajca
Journal:  Free Radic Res       Date:  2018-02-27

3.  Systemic DNA damage accumulation under in vivo tumor growth can be inhibited by the antioxidant Tempol.

Authors:  Alexandros G Georgakilas; Christophe E Redon; Nicholas F Ferguson; Thomas B Kryston; Palak Parekh; Jennifer S Dickey; Asako J Nakamura; James B Mitchell; William M Bonner; Olga A Martin
Journal:  Cancer Lett       Date:  2014-07-25       Impact factor: 8.679

4.  Electron spin-lattice relaxation mechanisms of rapidly-tumbling nitroxide radicals.

Authors:  Joshua R Biller; Hanan Elajaili; Virginia Meyer; Gerald M Rosen; Sandra S Eaton; Gareth R Eaton
Journal:  J Magn Reson       Date:  2013-08-22       Impact factor: 2.229

5.  A novel nitroxide is an effective brain redox imaging contrast agent and in vivo radioprotector.

Authors:  Ryan M Davis; Anastasia L Sowers; William DeGraff; Marcelino Bernardo; Angela Thetford; Murali C Krishna; James B Mitchell
Journal:  Free Radic Biol Med       Date:  2011-05-25       Impact factor: 7.376

6.  Organic radical contrast agents for magnetic resonance imaging.

Authors:  Andrzej Rajca; Ying Wang; Michael Boska; Joseph T Paletta; Arnon Olankitwanit; Michael A Swanson; Deborah G Mitchell; Sandra S Eaton; Gareth R Eaton; Suchada Rajca
Journal:  J Am Chem Soc       Date:  2012-09-17       Impact factor: 15.419

7.  Verdazyl-ribose: A new radical for solid-state dynamic nuclear polarization at high magnetic field.

Authors:  Kent R Thurber; Thanh-Ngoc Le; Victor Changcoco; David J R Brook
Journal:  J Magn Reson       Date:  2018-03-01       Impact factor: 2.229

Review 8.  Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.

Authors:  Jacek Zielonka; Joy Joseph; Adam Sikora; Micael Hardy; Olivier Ouari; Jeannette Vasquez-Vivar; Gang Cheng; Marcos Lopez; Balaraman Kalyanaraman
Journal:  Chem Rev       Date:  2017-06-27       Impact factor: 60.622

Review 9.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

10.  Tumor Xenograft Response to Redox-Active Therapies Assessed by Magnetic Resonance Imaging Using a Thiol-Bearing DOTA Complex of Gadolinium.

Authors:  Gerald P Guntle; Bhumasamudram Jagadish; Eugene A Mash; Garth Powis; Robert T Dorr; Natarajan Raghunand
Journal:  Transl Oncol       Date:  2012-06-01       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.